synthetic vaccines


Also found in: Wikipedia.

synthetic vaccines

prophylactic immunization substances prepared by artificial techniques, such as by peptide synthesis or cloning of deoxyribonucleic acid.
Mentioned in ?
References in periodicals archive ?
TLRPROSTATE will use advanced methods in synthetic biology to develop synthetic vaccines against prostate cancer, which is the second most common cancer worldwide for men.
Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients.
To get around the danger of using live viruses, scientists are working on synthetic vaccines for HIV and other viral infections such as hepatitis B.
AU is often used in protein engineering, synthetic vaccines, and drug purification and monitoring applications.
A It is hard to make synthetic vaccines as the viruses mutate so quickly.
It is hard to make synthetic vaccines because the viruses mutate so quickly that a vaccine which works on one strain may not work against others.
falciparum has withstood the best scientific weaponry, ranging from quinine to synthetic vaccines.
The commitment to the treatment of cancer currently focuses on the development of synthetic vaccines and novel strategies for cancer immunotherapy.
a clinical-stage biopharmaceutical company developing a new class of synthetic vaccines and immunotherapies, today announced that it has entered into a strategic global collaboration with Sanofi (EURONEXT: SAN and NYSE: SNY) to discover highly targeted, antigen-specific immunotherapies for life-threatening allergies.
a subsidiary of BTG plc (London, United Kingdom), a leading international technology transfer company, announced that it has signed a nonexclusive licensing agreement with Pasteur Merieux Connaught (Gulph Mills, PA; 610-313-4030), the world's leading vaccine company, granting rights to a fatty acid carrier technology for synthetic vaccines.
a clinical-stage biopharmaceutical company developing a new class of synthetic vaccines and immunotherapies, today announced that it has received the prestigious Edison Award for 2012 with the Gold Medal for Best Pharmaceutical Product Innovation.
a biopharmaceutical company developing a new class of synthetic vaccines and immunotherapies, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacodynamic profile of SEL-068, a nicotine vaccine candidate for smoking cessation and relapse prevention.